ArticlePoultry science2026
Eleutheroside B alleviates LPS-induced lung injury in chicks by regulating autophagy via the AMPK/mTOR signaling pathway.
Article in Poultry science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study explored the protective effect and molecular mechanism of Eleutheroside B (EB) against lipopolysaccharide (LPS)-induced lung injury in chicks, along with its hepatic and renal biosafety. A total of 60 seven-day-old SPF chicks (n=10 per group) were assigned to control, EB single treatment, LPS model, low/high-dose EB intervention and AMPK inhibitor (Compound C) groups. LPS intratracheal instillation was used to establish the chick acute lung injury model. Pulmonary pathological changes, pulmonary edema, inflammatory cytokine expression, autophagy-related proteins and the AMPK/mTOR pathway activation were detected via HE staining, ELISA, RT-PCR, immunohistochemistry and Western blot. Network pharmacology and molecular docking were further applied for mechanism validation. Results showed EB markedly relieved LPS-triggered pulmonary edema, alveolar damage and inflammatory infiltration, and downregulated serum TNF-α and IL-1β levels. EB activated AMPK, inhibited mTOR, elevated Beclin-1 expression and LC3-II/LC3-I ratio, indicating enhanced autophagosome formation and activation of autophagic markers. Molecular docking confirmed EB could stably bind to AMPK and mTOR. Moreover, EB had no obvious hepatotoxicity and nephrotoxicity. In conclusion, EB alleviates LPS-induced chick lung injury by regulating the AMPK/mTOR-mediated autophagy and inflammation, with good biosafety, offering a new candidate agent for poultry pneumonia prevention and treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.